IBDEI1AN ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23226,1,3,0)
 ;;=3^MOHS 1 Stage T/A/L
 ;;^UTILITY(U,$J,358.3,23227,0)
 ;;=17314^^136^1415^4^^^^1
 ;;^UTILITY(U,$J,358.3,23227,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23227,1,2,0)
 ;;=2^17314
 ;;^UTILITY(U,$J,358.3,23227,1,3,0)
 ;;=3^MOHS T/A/L,Ea Addl Stage
 ;;^UTILITY(U,$J,358.3,23228,0)
 ;;=17315^^136^1415^5^^^^1
 ;;^UTILITY(U,$J,358.3,23228,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23228,1,2,0)
 ;;=2^17315
 ;;^UTILITY(U,$J,358.3,23228,1,3,0)
 ;;=3^MOHS Surg Addl Block
 ;;^UTILITY(U,$J,358.3,23229,0)
 ;;=96372^^136^1416^8^^^^1
 ;;^UTILITY(U,$J,358.3,23229,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23229,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,23229,1,3,0)
 ;;=3^Ther/Proph/Diag Inj SC/IM
 ;;^UTILITY(U,$J,358.3,23230,0)
 ;;=96406^^136^1416^2^^^^1
 ;;^UTILITY(U,$J,358.3,23230,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23230,1,2,0)
 ;;=2^96406
 ;;^UTILITY(U,$J,358.3,23230,1,3,0)
 ;;=3^Chemo Intralesional > 7
 ;;^UTILITY(U,$J,358.3,23231,0)
 ;;=96405^^136^1416^1^^^^1
 ;;^UTILITY(U,$J,358.3,23231,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23231,1,2,0)
 ;;=2^96405
 ;;^UTILITY(U,$J,358.3,23231,1,3,0)
 ;;=3^Chemo Intralesional Up to 7
 ;;^UTILITY(U,$J,358.3,23232,0)
 ;;=C9800^^136^1416^3^^^^1
 ;;^UTILITY(U,$J,358.3,23232,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23232,1,2,0)
 ;;=2^C9800
 ;;^UTILITY(U,$J,358.3,23232,1,3,0)
 ;;=3^Dermal Filler Inj Px/Supply
 ;;^UTILITY(U,$J,358.3,23233,0)
 ;;=11901^^136^1416^7^^^^1
 ;;^UTILITY(U,$J,358.3,23233,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23233,1,2,0)
 ;;=2^11901
 ;;^UTILITY(U,$J,358.3,23233,1,3,0)
 ;;=3^Skin Lesion Injection,Addl Lesions
 ;;^UTILITY(U,$J,358.3,23234,0)
 ;;=11900^^136^1416^6^^^^1
 ;;^UTILITY(U,$J,358.3,23234,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23234,1,2,0)
 ;;=2^11900
 ;;^UTILITY(U,$J,358.3,23234,1,3,0)
 ;;=3^Skin Lesion Injection,Up to 7 Lesions
 ;;^UTILITY(U,$J,358.3,23235,0)
 ;;=Q2026^^136^1416^4^^^^1
 ;;^UTILITY(U,$J,358.3,23235,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23235,1,2,0)
 ;;=2^Q2026
 ;;^UTILITY(U,$J,358.3,23235,1,3,0)
 ;;=3^Radiesse Inj 0.1 ml
 ;;^UTILITY(U,$J,358.3,23236,0)
 ;;=Q2028^^136^1416^5^^^^1
 ;;^UTILITY(U,$J,358.3,23236,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23236,1,2,0)
 ;;=2^Q2028
 ;;^UTILITY(U,$J,358.3,23236,1,3,0)
 ;;=3^Sculptra Inj 0.5mg
 ;;^UTILITY(U,$J,358.3,23237,0)
 ;;=15780^^136^1417^6^^^^1
 ;;^UTILITY(U,$J,358.3,23237,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23237,1,2,0)
 ;;=2^15780
 ;;^UTILITY(U,$J,358.3,23237,1,3,0)
 ;;=3^Dermabrasion,Total Face
 ;;^UTILITY(U,$J,358.3,23238,0)
 ;;=15781^^136^1417^2^^^^1
 ;;^UTILITY(U,$J,358.3,23238,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23238,1,2,0)
 ;;=2^15781
 ;;^UTILITY(U,$J,358.3,23238,1,3,0)
 ;;=3^Dermabrasion,Segmental,Face
 ;;^UTILITY(U,$J,358.3,23239,0)
 ;;=15782^^136^1417^1^^^^1
 ;;^UTILITY(U,$J,358.3,23239,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23239,1,2,0)
 ;;=2^15782
 ;;^UTILITY(U,$J,358.3,23239,1,3,0)
 ;;=3^Dermabrasion,Regional,Not Face
 ;;^UTILITY(U,$J,358.3,23240,0)
 ;;=15783^^136^1417^5^^^^1
 ;;^UTILITY(U,$J,358.3,23240,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23240,1,2,0)
 ;;=2^15783
 ;;^UTILITY(U,$J,358.3,23240,1,3,0)
 ;;=3^Dermabrasion,Superficial
 ;;^UTILITY(U,$J,358.3,23241,0)
 ;;=15786^^136^1417^3^^^^1
 ;;^UTILITY(U,$J,358.3,23241,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23241,1,2,0)
 ;;=2^15786
 ;;^UTILITY(U,$J,358.3,23241,1,3,0)
 ;;=3^Dermabrasion,Single Lesion
 ;;^UTILITY(U,$J,358.3,23242,0)
 ;;=15787^^136^1417^4^^^^1
 ;;^UTILITY(U,$J,358.3,23242,1,0)
 ;;=^358.31IA^3^2
